Emergent BioSolutions ( NYSE:EBS ) Third Quarter 2024 Results Key Financial Results Revenue: US$293.8m (up 8.6% from 3Q... Emergent BioSolutions Inc (EBS) reports a robust financial performance ...

Can’t Find the Job of Your Choice? Never miss out on new jobs at HCLTech.